Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
22.83 BDT
18.98 B BDT
60.71 B BDT
574.71 M
About SQUARE PHARMACEUTICALS PLC
Sector
CEO
Tapan M. A. Chowdhury
Headquarters
Dhaka
Website
Founded
1958
ISIN
BD0473SQPH00
FIGI
BBG000CK4PZ3
Square Pharmaceuticals Plc engages in the provision of manufacture and marketing of pharmaceuticals, basic chemical, and animal health products. Its products include therapeutic, herbal, and nutraceuticals, as well as veterinary drugs and pesticides. The company was founded by Samson H. Chowdhury in 1958 and is headquartered in Dhaka, Bangladesh.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SQURPHARMA is 221.30 BDT — it has decreased by −0.23% in the past 24 hours. Watch SQUARE PHARMACEUTICALS PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on DSEBD exchange SQUARE PHARMACEUTICALS PLC stocks are traded under the ticker SQURPHARMA.
SQURPHARMA stock has risen by 1.10% compared to the previous week, the month change is a −2.08% fall, over the last year SQUARE PHARMACEUTICALS PLC has showed a 4.93% increase.
We've gathered analysts' opinions on SQUARE PHARMACEUTICALS PLC future price: according to them, SQURPHARMA price has a max estimate of 309.40 BDT and a min estimate of 303.00 BDT. Watch SQURPHARMA chart and read a more detailed SQUARE PHARMACEUTICALS PLC stock forecast: see what analysts think of SQUARE PHARMACEUTICALS PLC and suggest that you do with its stocks.
SQURPHARMA reached its all-time high on Jan 23, 2018 with the price of 278.67 BDT, and its all-time low was 104.05 BDT and was reached on Jan 7, 2013. View more price dynamics on SQURPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SQURPHARMA stock is 1.95% volatile and has beta coefficient of 0.62. Track SQUARE PHARMACEUTICALS PLC stock price on the chart and check out the list of the most volatile stocks — is SQUARE PHARMACEUTICALS PLC there?
Today SQUARE PHARMACEUTICALS PLC has the market capitalization of 196.62 B, it has increased by 1.30% over the last week.
Yes, you can track SQUARE PHARMACEUTICALS PLC financials in yearly and quarterly reports right on TradingView.
SQUARE PHARMACEUTICALS PLC is going to release the next earnings report on Nov 15, 2024. Keep track of upcoming events with our Earnings Calendar.
SQURPHARMA net income for the last quarter is 4.92 B BDT, while the quarter before that showed 5.24 B BDT of net income which accounts for −6.14% change. Track more SQUARE PHARMACEUTICALS PLC financial stats to get the full picture.
Yes, SQURPHARMA dividends are paid annually. The last dividend per share was 10.50 BDT. As of today, Dividend Yield (TTM)% is 4.73%. Tracking SQUARE PHARMACEUTICALS PLC dividends might help you take more informed decisions.
SQUARE PHARMACEUTICALS PLC dividend yield was 5.00% in 2023, and payout ratio reached 49.04%. The year before the numbers were 4.61% and 48.82% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 7, 2024, the company has 12.50 K employees. See our rating of the largest employees — is SQUARE PHARMACEUTICALS PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SQUARE PHARMACEUTICALS PLC EBITDA is 19.97 B BDT, and current EBITDA margin is 31.19%. See more stats in SQUARE PHARMACEUTICALS PLC financial statements.
Like other stocks, SQURPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SQUARE PHARMACEUTICALS PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SQUARE PHARMACEUTICALS PLC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SQUARE PHARMACEUTICALS PLC stock shows the buy signal. See more of SQUARE PHARMACEUTICALS PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.